HEADER IMMUNE SYSTEM 04-FEB-14 2MK9 TITLE SPATIAL STRUCTURE OF THE DIMERIC TRANSMEMBRANE DOMAIN OF TOLL-LIKE TITLE 2 RECEPTOR 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TRANSMEMBRANE DOMAIN (UNP RESIDUES 698-730); COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TLR3; SOURCE 6 EXPRESSION_SYSTEM: CELL-FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS TRANSMEMBRANE DOMAIN, DIMER, IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR K.S.MINEEV,S.A.GONCHARUK,A.S.ARSENIEV REVDAT 3 17-DEC-14 2MK9 1 JRNL REVDAT 2 01-OCT-14 2MK9 1 JRNL REVDAT 1 17-SEP-14 2MK9 0 JRNL AUTH K.S.MINEEV,S.A.GONCHARUK,A.S.ARSENIEV JRNL TITL TOLL-LIKE RECEPTOR 3 TRANSMEMBRANE DOMAIN IS ABLE TO PERFORM JRNL TITL 2 VARIOUS HOMOTYPIC INTERACTIONS: AN NMR STRUCTURAL STUDY. JRNL REF FEBS LETT. V. 588 3802 2014 JRNL REFN ISSN 0014-5793 JRNL PMID 25217833 JRNL DOI 10.1016/J.FEBSLET.2014.08.031 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-14. REMARK 100 THE RCSB ID CODE IS RCSB103714. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 318 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.8 MM TOLL-LIKE RECEPTOR 3, 1.2 REMARK 210 MM [U-98% 13C; U-98% 15N] TOLL- REMARK 210 LIKE RECEPTOR 3, 20 MM POTASSIUM REMARK 210 PHOSPHATE, 1 MM SODIUM AZIDE, 200 REMARK 210 MM [U-99% 2H] DPC, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HNCO; 3D HN(CO)CA; 3D HCCH-TOCSY; REMARK 210 3D 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D HCCH-COSY; 13C/15N- REMARK 210 FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.0, CARA 1.8.5, CYANA REMARK 210 3.0, TALOS +, QMDD 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 ARG B 133 37.89 -99.17 REMARK 500 4 ARG A 33 82.83 -150.80 REMARK 500 4 SER B 103 37.18 -99.43 REMARK 500 5 ARG B 133 44.93 -106.47 REMARK 500 8 ARG A 33 51.27 -90.43 REMARK 500 8 ARG B 133 51.69 -91.14 REMARK 500 10 SER A 3 35.51 -99.01 REMARK 500 10 SER B 103 35.39 -99.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19764 RELATED DB: BMRB REMARK 900 RELATED ID: 2MKA RELATED DB: PDB DBREF 2MK9 A 2 34 UNP O15455 TLR3_HUMAN 698 730 DBREF 2MK9 B 102 134 UNP O15455 TLR3_HUMAN 698 730 SEQADV 2MK9 MET A 1 UNP O15455 INITIATING METHIONINE SEQADV 2MK9 MET B 101 UNP O15455 INITIATING METHIONINE SEQRES 1 A 34 MET ASP SER ALA PRO PHE GLU LEU PHE PHE MET ILE ASN SEQRES 2 A 34 THR SER ILE LEU LEU ILE PHE ILE PHE ILE VAL LEU LEU SEQRES 3 A 34 ILE HIS PHE GLU GLY TRP ARG ILE SEQRES 1 B 34 MET ASP SER ALA PRO PHE GLU LEU PHE PHE MET ILE ASN SEQRES 2 B 34 THR SER ILE LEU LEU ILE PHE ILE PHE ILE VAL LEU LEU SEQRES 3 B 34 ILE HIS PHE GLU GLY TRP ARG ILE HELIX 1 1 SER A 3 TRP A 32 1 30 HELIX 2 2 SER B 103 TRP B 132 1 30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 102 0 0 2 0 0 0 6 0 0 0 6 END